第六批国家组织高值医用耗材集采开标，五月前后可落地实施 泌尿系统结石手术耗材首次纳入 有望缩减结石病整体治疗费用

Core Insights - The sixth batch of centralized procurement for high-value medical consumables in China has been conducted, involving 12 types of medical consumables with 496 products from 227 companies bidding, and 440 products from 202 companies selected [1] Group 1: Procurement Details - The procurement includes drug-coated balloons and urological intervention consumables, marking the first inclusion of urological stone surgery-related consumables, which were previously a gap in the procurement process [1] - Key consumables for urological stone surgeries, such as ureteral intervention guidewires and balloons, were included, with 454 products from 195 companies bidding and 398 products from 170 companies selected [1] - The inclusion of these consumables is expected to significantly reduce the overall treatment costs for stone diseases, which previously ranged from 20,000 to 30,000 yuan [1] Group 2: Impact on Healthcare Costs - The inclusion of drug-coated balloons is anticipated to benefit more patients, complementing previous stent procurement efforts that lowered medical costs [2] - A total of 42 products from 32 companies for drug-coated balloons were selected, demonstrating a high match with clinical usage and potentially alleviating the financial burden on patients [2] Group 3: Procurement Policy and Innovation - The procurement process has been optimized to prevent malicious low pricing while encouraging technological innovation, adhering to principles of clinical stability, quality assurance, and anti-competitive practices [2] - The grouping of products based on demand and supply capabilities ensures that clinically recognized and capable products are selected, maintaining continuity in clinical usage [2] - The procurement rules have been adjusted to prevent price undercutting, with a baseline price control set at 65% of the average price when the lowest bid is excessively low, impacting 8 out of 20 competitive groups [2] Group 4: Broader Context - The national medical insurance department has successfully procured 142 types of medical consumables across nine major categories, covering various clinical fields including cardiology, orthopedics, and urology [3] - This procurement is expected to be implemented by May 2026 [3]